MRD-negative response rate in four patients; all remain in response through the longest follow up of 5 monthsFavorable ...

A leading specialist in medically supervised alcohol reduction says moderate wine consumption this Christmas could actually ...

Nearly one in four European pharmaceutical companies remains vulnerable to regulatory risks due to inadequate quality systems ...

Partnering Platform Now Open for RegistrationSAN FRANCISCO--(BUSINESS WIRE)--#biotechshowcase--Biotech Showcase™ returns to ...

Acquisition of Vectura strengthened inhalation capabilities, driving innovation and portfolio expansion in less than one ...

Engagement solutions leader acquires C2events in England and Daymakers in the Netherlands, strengthening their ability to ...

Indero, a global CRO specializing in dermatology and rheumatology, has been honored by Mercer, recognizing its excellence as ...

The global microplate systems market is projected to grow at a compound annual growth rate (CAGR) of approximately 4% over ...

The global intravenous (IV) fluid bags market is projected to grow at a compound annual growth rate (CAGR) of approximately 6 ...

The global pressure monitoring market is anticipated to expand at a compound annual growth rate (CAGR) of around 8% during ...

Breakthrough Therapy Designation is based on FDA’s review of survival analyses comparing adrabetadex-treated patients with external controls and marks a significant regulatory milestone ahead of an ...

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced it has filed an amended registration statement on ...